Extensions for Using Data Elements from FHIR STU3 in FHIR R5
0.1.0 - STU
Extensions for Using Data Elements from FHIR STU3 in FHIR R5
0.1.0 - STU
Extensions for Using Data Elements from FHIR STU3 in FHIR R5 - Downloaded Version null See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 0 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="R3-v3-ParticipationTargetDirect-for-R5"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet R3-v3-ParticipationTargetDirect-for-R5</b></p><a name="R3-v3-ParticipationTargetDirect-for-R5"> </a><a name="hcR3-v3-ParticipationTargetDirect-for-R5"> </a><p>This value set expansion contains 17 concepts.</p><table class="codes"><tr><td><b>System</b></td><td><b>Version</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-ALY"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-ALY">ALY</a></td><td>analyte</td><td><div><p>The target of an Observation action. Links an observation to a Role whose player is the substance or most specific component entity (material, micro-organism, etc.) being measured within the subject.</p>
<pre><code> Examples: A "plasma porcelain substance concentration" has analyte a Role with player substance Entity "porcelain".
UsageNotes: The Role that this participation connects to may be any Role whose player is that substance measured. Very often, the scoper may indicate the system in which the component is being measured. E.g., for "plasma porcelain" the scoper could be "Plasma".
</code></pre>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-BBY"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-BBY">BBY</a></td><td>baby</td><td><div><p>In an obstetric service, the baby.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-CAT"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-CAT">CAT</a></td><td>catalyst</td><td><div><p>The catalyst of a chemical reaction, such as an enzyme or a platinum surface. In biochemical reactions, connects the enzyme with the molecular interaction</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-CSM"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-CSM">CSM</a></td><td>consumable</td><td><div><p>Participant material that is taken up, diminished, altered, or disappears in the act.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-DEV"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-DEV">DEV</a></td><td>device</td><td><div><p>Participant used in performing the act without being substantially affected by the act (i.e. durable or inert with respect to that particular service).</p>
<pre><code> Examples: monitoring equipment, tools, but also access/drainage lines, prostheses, pace maker, etc.
</code></pre>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-DIR"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-DIR">DIR</a></td><td>direct target</td><td><div><p>Target participant that is substantially present in the act and which is directly involved in the action (includes consumed material, devices, etc.).</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-DON"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-DON">DON</a></td><td>donor</td><td><div><p>In some organ transplantation services and rarely in transfusion services a donor will be a target participant in the service. However, in most cases transplantation is decomposed in three services: explantation, transport, and implantation. The identity of the donor (recipient) is often irrelevant for the explantation (implantation) service.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-EXPAGNT"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-EXPAGNT">EXPAGNT</a></td><td>ExposureAgent</td><td><div><p>Description: The entity playing the associated role is the physical (including energy), chemical or biological substance that is participating in the exposure. For example in communicable diseases, the associated playing entity is the disease causing pathogen.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-EXPART"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-EXPART">EXPART</a></td><td>ExposureParticipation</td><td><div><p>Description:Direct participation in an exposure act where it is unknown that the participant is the source or subject of the exposure. If the participant is known to be the contact of an exposure then the SBJ participation type should be used. If the participant is known to be the source then the EXSRC participation type should be used.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-EXPTRGT"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-EXPTRGT">EXPTRGT</a></td><td>ExposureTarget</td><td><div><p>Description: The entity playing the associated role is the target (contact) of exposure.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-EXSRC"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-EXSRC">EXSRC</a></td><td>ExposureSource</td><td><div><p>Description:The entity playing the associated role is the source of exposure.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-NRD"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-NRD">NRD</a></td><td>non-reuseable device</td><td><div><p>A device that changes ownership due to the service, e.g., a pacemaker, a prosthesis, an insulin injection equipment (pen), etc. Such material may need to be restocked after he service.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-PRD"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-PRD">PRD</a></td><td>product</td><td><div><p>Participant material that is brought forth (produced) in the act (e.g., specimen in a specimen collection, access or drainage in a placement service, medication package in a dispense service). It does not matter whether the material produced had existence prior to the service, or whether it is created in the service (e.g., in supply services the product is taken from a stock).</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-RDV"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-RDV">RDV</a></td><td>reusable device</td><td><div><p>A device that does not change ownership due to the service, i.e., a surgical instrument or tool or an endoscope. The distinction between reuseable and non-reuseable must be made in order to know whether material must be re-stocked.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-SBJ"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-SBJ">SBJ</a></td><td>subject</td><td><div><p>The principle target on which the action happens.</p>
<pre><code> Examples: The patient in physical examination, a specimen in a lab observation. May also be a patient's family member (teaching) or a device or room (cleaning, disinfecting, housekeeping).
UsageNotes: Not all direct targets are subjects. Consumables and devices used as tools for an act are not subjects. However, a device may be a subject of a maintenance action.
</code></pre>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-SPC"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-SPC">SPC</a></td><td>specimen</td><td><div><p>The subject of non-clinical (e.g. laboratory) observation services is a specimen.</p>
</div></td></tr><tr><td><a name="R3-v3-ParticipationTargetDirect-for-R5-http://hl7.org/fhir/v3/ParticipationType-TPA"> </a><code>http://hl7.org/fhir/v3/ParticipationType</code></td><td>2016-11-11</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-ParticipationType.html#v3-ParticipationType-TPA">TPA</a></td><td>therapeutic agent</td><td><div><p>Something incorporated in the subject of a therapy service to achieve a physiologic effect (e.g., heal, relieve, provoke a condition, etc.) on the subject. In an administration service the therapeutic agent is a consumable, in a preparation or dispense service, it is a product. Thus, consumable or product must be specified in accordance with the kind of service.</p>
</div></td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="0"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="fhir"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/package-source">
<extension url="packageId">
<valueId value="hl7.fhir.uv.xver-r3.r5"/>
</extension>
<extension url="version">
<valueString value="0.1.0"/>
</extension>
<extension url="uri">
<valueUri
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r5"/>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r5"/>
</extension>
</valueCode>
</extension>
<url
value="http://hl7.org/fhir/uv/xver/ValueSet/R3-v3-ParticipationTargetDirect-for-R5"/>
<version value="0.1.0"/>
<name value="R3V3ParticipationTargetDirectForR5"/>
<title
value="Cross-version ValueSet STU3.ParticipationTargetDirect for use in FHIR R5"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-03-17T21:02:03.8104715+00:00"/>
<publisher value="FHIR Infrastructure"/>
<contact>
<name value="FHIR Infrastructure"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/fiwg"/>
</telecom>
</contact>
<description
value="This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26` for use in FHIR R5."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<purpose
value="This value set is part of the cross-version definitions generated to enable use of the
value set `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26` as defined in FHIR STU3
in FHIR R5.
The source value set is bound to the following FHIR STU3 elements:
*
Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-ParticipationTargetDirect|2014-03-26`, defined in FHIR STU3 does not have any mapping to FHIR R5"/>
<compose>
<include>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<concept>
<code value="ALY"/>
<display value="analyte"/>
</concept>
<concept>
<code value="BBY"/>
<display value="baby"/>
</concept>
<concept>
<code value="CAT"/>
<display value="catalyst"/>
</concept>
<concept>
<code value="CSM"/>
<display value="consumable"/>
</concept>
<concept>
<code value="DEV"/>
<display value="device"/>
</concept>
<concept>
<code value="DIR"/>
<display value="direct target"/>
</concept>
<concept>
<code value="DON"/>
<display value="donor"/>
</concept>
<concept>
<code value="EXPAGNT"/>
<display value="ExposureAgent"/>
</concept>
<concept>
<code value="EXPART"/>
<display value="ExposureParticipation"/>
</concept>
<concept>
<code value="EXPTRGT"/>
<display value="ExposureTarget"/>
</concept>
<concept>
<code value="EXSRC"/>
<display value="ExposureSource"/>
</concept>
<concept>
<code value="NRD"/>
<display value="non-reuseable device"/>
</concept>
<concept>
<code value="PRD"/>
<display value="product"/>
</concept>
<concept>
<code value="RDV"/>
<display value="reusable device"/>
</concept>
<concept>
<code value="SBJ"/>
<display value="subject"/>
</concept>
<concept>
<code value="SPC"/>
<display value="specimen"/>
</concept>
<concept>
<code value="TPA"/>
<display value="therapeutic agent"/>
</concept>
</include>
</compose>
<expansion>
<timestamp value="2026-03-17T21:02:03.8104715+00:00"/>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="ALY"/>
<display value="analyte"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="BBY"/>
<display value="baby"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="CAT"/>
<display value="catalyst"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="CSM"/>
<display value="consumable"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="DEV"/>
<display value="device"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="DIR"/>
<display value="direct target"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="DON"/>
<display value="donor"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="EXPAGNT"/>
<display value="ExposureAgent"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="EXPART"/>
<display value="ExposureParticipation"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="EXPTRGT"/>
<display value="ExposureTarget"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="EXSRC"/>
<display value="ExposureSource"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="NRD"/>
<display value="non-reuseable device"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="PRD"/>
<display value="product"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="RDV"/>
<display value="reusable device"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="SBJ"/>
<display value="subject"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="SPC"/>
<display value="specimen"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/ParticipationType"/>
<version value="2016-11-11"/>
<code value="TPA"/>
<display value="therapeutic agent"/>
</contains>
</expansion>
</ValueSet>
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r3.r5#0.1.0 based on FHIR 5.0.0. Generated 2026-03-20
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change